You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Exercise Disclosure
Sandler Laura Lee · SEC Form 4 · Filed Sep 1, 2026
Exercise
Calculated transaction value
$0
Sandler Laura Lee Chief Operating Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$92.11
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Warrant (right to buy) on Common Stock
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000907654-26-000088
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$498.1K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 1, 2026 | $91.05K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 1, 2026 | $39K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 1, 2026 | $368.05K |
| Oruka Therapeutics, Inc. ORKA Current | Exercise | Sep 1, 2026 | $0 |